RTW INVESTMENTS, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Stoke Therapeutics, Inc. Common Stock, par value $0.0001 per share (STOK)

Filing Manager: RTW INVESTMENTS, LP
Reporting Manager: RTW Investments, LP
Security: Stoke Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: STOK
Shares outstanding: 53.2M shares
Disclosed Ownership: 5.31M shares
Ownership: 9.99%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 09:00:07 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
RTW Investments, LP	9.99%	5.31M	0	5.31M	/s/ Roderick Wong, M.D.	Roderick Wong, M.D., Managing Partner
Roderick Wong, M.D.	9.99%	5.31M	0	5.31M	/s/ Roderick Wong, M.D.	Roderick Wong, M.D.